Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design

被引:57
|
作者
Todorov, NP
Dean, PM
机构
[1] Department of Pharmacology, University of Cambridge, Cambridge CB2 1QJ, Tennis Court Road
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
simulated annealing; drug design; penalty function optimization; molecular diversity;
D O I
10.1023/A:1008042711516
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe an algorithm for the automated generation of molecular structures subject to geometric and connectivity constraints. The method relies on simulated annealing and simplex optimization of a penalty function that contains a variety of conditions and can be useful in structure-based drug design projects. The procedure controls the diversity and complexity of the generated molecules. Structure selection filters are an integral part and drive the algorithm. Several procedures have been developed to achieve reliable control. A number of template sets can be defined and combined to control the range of molecules which are searched. Ring systems are predefined. Normally, the ring-system complexity is one of the most elusive and difficult factors to control when fusion-, bridge- and spiro-structures are built by joining templates. Here this is not an issue; the decision about which systems are acceptable, and which are not, is made before the run is initiated. Queries for inclusion and exclusion spheres are incorporated into the objective function, and, by using a flexible notation,the structure generation can be directed and more focused. Simulated annealing is a reliable optimizer and converges asymptotically to the global minimum. The objective functions used here are degenerate, so it is likely that each run will produce a different set of good solutions.
引用
收藏
页码:175 / 192
页数:18
相关论文
共 50 条
  • [1] Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design
    N.P. Todorov
    P.M. Dean
    Journal of Computer-Aided Molecular Design, 1997, 11 : 175 - 192
  • [2] Scaffold hopping in de novo design. Ligand generation in the absence of receptor information
    Lloyd, DG
    Buenemann, CL
    Todorov, NP
    Manallack, DT
    Dean, PM
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 493 - 496
  • [3] De novo chemical ligand design
    Chan, TF
    Zheng, XFS
    DRUG DISCOVERY TODAY, 2002, 7 (15) : 802 - 803
  • [4] The effect of a tightly bound water molecule on scaffold diversity in the computer-aided de novo ligand design of CDK2 inhibitors
    Alfonso T. García-Sosa
    Ricardo L. Mancera
    Journal of Molecular Modeling, 2006, 12 : 422 - 431
  • [5] The effect of a tightly bound water molecule on scaffold diversity in the computer-aided de novo ligand design of CDK2 inhibitors
    García-Sosa, AT
    Mancera, RL
    JOURNAL OF MOLECULAR MODELING, 2006, 12 (04) : 422 - 431
  • [6] Recent developments in de novo design and scaffold hopping
    Mauser, Harald
    Guba, Wolfgang
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (03) : 365 - 374
  • [7] The use of ligand-based de novo design for scaffold hopping and sidechain optimization: Two case studies
    Feher, Miklos
    Gao, Yinghong
    Baber, J. Christian
    Shirley, William A.
    Saunders, John
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 422 - 427
  • [8] De Novo Design and Synthesis of a -Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric Ligand
    Kim, Mi-hyun
    Lee, Junghun
    Hah, Jung-Mi
    CHEMISTRY-AN ASIAN JOURNAL, 2015, 10 (06) : 1318 - 1326
  • [9] Design and optimization of enzymatic activity in a de novo β-barrel scaffold
    Kipnis, Yakov
    Chaib, Anissa Ouald
    Vorobieva, Anastassia A.
    Cai, Guangyang
    Reggiano, Gabriella
    Basanta, Benjamin
    Kumar, Eshan
    Mittl, Peer R. E.
    Hilvert, Donald
    Baker, David
    PROTEIN SCIENCE, 2022, 31 (11)
  • [10] De novo design of novel emulsifiers based on a protein scaffold
    Annan, W. S.
    van der Walle, C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S61 - S61